Home›Search›Expert Review of Pharmacoeconomics and Outcomes Research

Expert Review of Pharmacoeconomics and Outcomes Research

Taylor and Francis Ltd. · United Kingdom · Est. 1976

ISSN1473-7167eISSN1744-8379

SJR Q3✓ WOS SCIE✓ WOS SSCI✓ Scopus / SJR

Impact Factor & Quartile · Web of Science (JCR)

✓ Indexed in the Web of Science Core Collection (SCIE · SSCI) — Clarivate publishes an official Journal Impact Factor and JCR quartile for this journal.

See the official Impact Factor & quartile on the journal’s page ↗

The Impact Factor & JCR quartile are licensed by Clarivate — we link you to the official source instead of reprinting a number that can go out of date. Open metrics below: SCImago Q3. Source: Clarivate Journal Citation Reports.

📊 Standing in its field

Where this journal ranks among others in the same subject area.

SJR · Scopus

Top 75% in field

Clarivate’s JCR quartile is a separate ranking and may differ

SJR Scorei

0.511

H-Indexi

SNIPi

0.662

Total Worksi

2,294

Total Citationsi

37,377

2yr Mean Citednessi

1.56

Open Impact Factor alternative

Aims & Scope

Subject areas: Health Care Sciences & Services; Health Policy & Services; Pharmacology & Pharmacy; Health Policy; Medicine (miscellaneous); Pharmacology (medical).

General Information

Country / RegionUnited Kingdom

Primary LanguageEnglish

1st Year Published1976

FrequencyBimonthly

StatusActive (last: 2026)

Total Publications2,294

Publisher OrgTaylor & Francis

Visit Journal Website

Submission Info

Peer Review—

OA License—

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Think.Check.Submit Compliance

thinkchecksubmit.org

6/11 · 55%

✅

Do you know the journal / publisher?

Taylor and Francis Ltd.

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

1473-7167 / 1744-8379

✅

Indexed in a trusted database?

WoS, Scopus

❌

Peer review process documented?

N/A

❌

Follows ethical publishing standards (COPE)?

N/A

✅

Not on predatory/blacklists?

✓ Clean

❌

Long-term digital preservation?

N/A

❌

Plagiarism detection in place?

N/A

❌

Listed in DOAJ (verified OA)?

N/A

✅

Primary language documented?

English

A twelfth criterion — whether APC fees are clearly disclosed — is not scored here; it is left out of the total rather than counted as a failure. Publication charges appear in the metrics card above.

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Citations received

1.4k

2019

102

2.2k

2020

123

1.4k

2021

518

2022

131

804

2023

120

443

2024

129

166

2025

2026

Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

Health PolicyQ3

Medicine (miscellaneous)Q3

Pharmacology (medical)Q3

Subject Classification

Web of Science Categories

Health Care Sciences & ServicesHealth Policy & ServicesPharmacology & Pharmacy

Scopus Categories

Pharmacology (medical)Medicine (miscellaneous)Health Policy

Research Topics (OpenAlex)

Health Systems, Economic Evaluations, Quality of LifePharmaceutical Economics and PolicyEconomic and Financial Impacts of CancerHealthcare Policy and ManagementGlobal Health Care IssuesMedication Adherence and ComplianceHealthcare cost, quality, practicesEconomic and Environmental ValuationBiosimilars and Bioanalytical MethodsCancer survivorship and care

Frequently asked questions about Expert Review of Pharmacoeconomics and Outcomes Research

Is Expert Review of Pharmacoeconomics and Outcomes Research a predatory journal?

PubScope has no integrity flags on record for Expert Review of Pharmacoeconomics and Outcomes Research: it is indexed in Web of Science, Scopus, and is not on DOAJ's withdrawn list. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.

What is the impact factor of Expert Review of Pharmacoeconomics and Outcomes Research?

Expert Review of Pharmacoeconomics and Outcomes Research is indexed in the Web of Science Core Collection, so Clarivate publishes an official Journal Impact Factor for it (since the 2023 Journal Citation Reports, every Core Collection journal — including Arts & Humanities and Emerging Sources titles — receives one). PubScope links to Clarivate's official source rather than reprinting the number, which can be out of date. Its open 2-year mean citedness is 1.56.

Is Expert Review of Pharmacoeconomics and Outcomes Research indexed in Scopus and Web of Science?

Expert Review of Pharmacoeconomics and Outcomes Research is indexed in Web of Science, Scopus.

What is the aims and scope of Expert Review of Pharmacoeconomics and Outcomes Research?